U.S., June 16 -- ClinicalTrials.gov registry received information related to the study (NCT07647549) titled 'Pulmonary Hypertension (PH) Biorepository for Translational Research' on June 12.

Brief Summary: Study Description:

This study aims to establish a biorepository based on the World Symposium Pulmonary Hypertension (PH) Groups 1-5. In the future, IRB approved protocols may use these blood samples to discover novel, biologically relevant, non-invasive PH biomarkers. In combination with clinical data these potential biomarkers will be used to distinguish PH groups, elucidate underlying molecular phenotypes, predict clinically relevant outcomes, as well as discriminate healthy (healthy subjects will not be enrolled under this protocol) ...